An advanced treatment approach that leverages a patient’s own immune cells to seek out and destroy cancer cells.

Through dendritic cell therapy, the body’s immune system can be recalibrated to its “healthy baseline,” enabling it to quickly identify and target cancer cells. This breakthrough paves the way for a safer, more effective, and longer-lasting strategy against cancer. It brings unprecedented hope to countless patients.

Through LAK therapy, patients can rapidly strengthen their immune response, effectively targeting and suppressing cancer cells. Additionally, when combined with other treatments—such as dendritic cell (DC) vaccine therapy—or conventional methods, LAK therapy can yield even more comprehensive, synergistic benefits in the battle against cancer.

NK therapy delivers a robust immune offensive against severe diseases and cancer cells. When combined with other treatments—such as LAK therapy, dendritic cell (DC) vaccines, or conventional strategies—it often demonstrates synergistic benefits, providing patients with a proactive route back to health.

Compared to conventional treatments like chemotherapy and radiotherapy, immunotherapy generally has fewer side effects and allows patients to maintain a higher quality of life.

Overall, immunotherapy side effects tend to be less severe than those seen in chemotherapy or radiotherapy, offering new hope to patients in their battle against serious diseases. By working closely with experienced physicians and maintaining healthy habits and a positive mindset, patients can minimize side effects and improve their odds of overcoming illness.

Compared to conventional treatments (chemotherapy, radiotherapy), immunotherapy costs are typically higher, driven by factors like research and development, drug procurement, specialized lab techniques, and a skilled medical team. However, as the technology matures, some treatments and medications are increasingly covered by insurance or governmental support, gradually reducing their out-of-pocket expense.